All results

3 results for stronger study

• Phase I/II Study of Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patie

  Patients with breast cancer are commonly treated with taxane chemotherapy. Some very common side effects of taxanes, such as anemia and peripheral neuropathy,…

  Ages

  18 Years - 99 Years

  Sexes

  All

• DOTS (20-0002)

  This is a Phase 2b clinical study, multicenter, randomized, open-label, assessor-blinded, superiority study. The study will compare dalbavancin to standard of…

  Ages

  18 Years - 99 Years

  Sexes

  All

• EVOLVE

  The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipid…

  Ages

  18 Years - 99 Years

  Sexes

  All